Camp4 Therapeutics Corporation · NASDAQ:CAMP

Schwab Andrew J. sold 191,865 Camp4 Therapeutics Corporation shares (Form 4)

Traded Aug 19 to Aug 21, 2026 · Filed Aug 21, 2026

From Aug 19 to Aug 21, 2026, Schwab Andrew J. (Director) sold 191,865 Camp4 Therapeutics Corporation shares at an average US$4.59 for US$880K, leaving 2,433,280 shares. Filed Aug 21, 2026 (Form 4).

Sold
191,865 shares
Price
US$4.59 average (US$4.50 to US$4.76)
Value
US$880K
Holding after
2,433,280 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 19, 2026Common StockSale45,147US$4.762,579,998Indirect
Aug 20, 2026Common StockSale114,700US$4.542,465,298Indirect
Aug 21, 2026Common StockSale32,018US$4.502,433,280Indirect

Source

View original at SEC

Related